These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 16199912)

  • 21. Comparative effects of azelnidipine and other Ca2+-channel blockers on the induction of inducible nitric oxide synthase in vascular smooth muscle cells.
    Ma J; Kishida S; Wang GQ; Meguro K; Imuta H; Oonuma H; Iida H; Jo T; Takano H; Morita T; Nagai R; Nakajima T
    J Cardiovasc Pharmacol; 2006 Feb; 47(2):314-21. PubMed ID: 16495772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Vascular endothelium--function, disorders and clinical modification probes].
    Leśniak W; Kolasińska-Kloch W; Kieć B
    Folia Med Cracov; 2001; 42(1-2):5-14. PubMed ID: 11712325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcium channel blockades exhibit anti-inflammatory and antioxidative effects by augmentation of endothelial nitric oxide synthase and the inhibition of angiotensin converting enzyme in the N(G)-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure-lowering effects of amlodipine and manidipine.
    Toba H; Nakagawa Y; Miki S; Shimizu T; Yoshimura A; Inoue R; Asayama J; Kobara M; Nakata T
    Hypertens Res; 2005 Aug; 28(8):689-700. PubMed ID: 16392774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure.
    Yamamoto E; Kataoka K; Shintaku H; Yamashita T; Tokutomi Y; Dong YF; Matsuba S; Ichijo H; Ogawa H; Kim-Mitsuyama S
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2569-75. PubMed ID: 17932313
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel therapeutic strategies targeting vascular endothelium in essential hypertension.
    Tousoulis D; Papageorgiou N; Androulakis E; Paroutoglou K; Stefanadis C
    Expert Opin Investig Drugs; 2010 Nov; 19(11):1395-412. PubMed ID: 20923260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of calcium channel blockers in atherosclerosis and cardiovascular event and oxidative vascular damage].
    Fujino T; Sumitomo K; Hasebe N; Kikuchi K
    Clin Calcium; 2004 Jan; 14(1):119-27. PubMed ID: 15576967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Endothelial dysfunction as an early sign of atherosclerosis.
    Giannotti G; Landmesser U
    Herz; 2007 Oct; 32(7):568-72. PubMed ID: 17972030
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucosyl hesperidin prevents endothelial dysfunction and oxidative stress in spontaneously hypertensive rats.
    Yamamoto M; Suzuki A; Jokura H; Yamamoto N; Hase T
    Nutrition; 2008 May; 24(5):470-6. PubMed ID: 18329851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP; Zinchuk VV
    Clin Physiol Funct Imaging; 2009 May; 29(3):170-6. PubMed ID: 19170724
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endothelial dysfunction and chronic kidney disease: treatment options.
    Wu-Wong JR
    Curr Opin Investig Drugs; 2008 Sep; 9(9):970-82. PubMed ID: 18729004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Translocation of endothelial nitric oxide synthase: another feat of amlodipine, a cardiovascular jack-of-all-trades.
    Mayer B
    Cardiovasc Res; 2006 Aug; 71(3):411-3. PubMed ID: 16820143
    [No Abstract]   [Full Text] [Related]  

  • 33. Efonidipine simultaneously improves blood pressure, endothelial function, and metabolic parameters in nondiabetic patients with hypertension.
    Koh KK; Quon MJ; Lee SJ; Han SH; Ahn JY; Kim JA; Chung WJ; Lee Y; Shin EK
    Diabetes Care; 2007 Jun; 30(6):1605-7. PubMed ID: 17351278
    [No Abstract]   [Full Text] [Related]  

  • 34. [Anti-hypertensive drugs associated with the improvement of endothelial function].
    Yoshimoto T; Hirata Y
    Nihon Rinsho; 2004 Jan; 62(1):128-34. PubMed ID: 14737845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Obesity and endothelial dysfunction].
    Taddei S; Ghiadoni L; Salvetti G; Virdis A; Salvetti A
    G Ital Cardiol (Rome); 2006 Nov; 7(11):715-23. PubMed ID: 17216913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelin receptor antagonists as antihypertensives: the next frontier.
    Epstein BJ; Anderson S
    Expert Rev Cardiovasc Ther; 2009 Jun; 7(6):675-87. PubMed ID: 19505283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heart rate reduction by ivabradine reduces oxidative stress, improves endothelial function, and prevents atherosclerosis in apolipoprotein E-deficient mice.
    Custodis F; Baumhäkel M; Schlimmer N; List F; Gensch C; Böhm M; Laufs U
    Circulation; 2008 May; 117(18):2377-87. PubMed ID: 18443241
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atheroprotective properties of nifedipine.
    Yamagishi S; Takeuchi M
    Int J Tissue React; 2005; 27(2):63-7. PubMed ID: 16035650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting mechanisms of hypertensive vascular disease with dual calcium channel and renin-angiotensin system blockade.
    Weir MR
    J Hum Hypertens; 2007 Oct; 21(10):770-9. PubMed ID: 17597800
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.